Using real-time reverse transcription-PCR (RT-qPCR), we discovered that several canonical stem cell makers, including NANOG, CD133, and OCT4, were up-regulated in the soft-fibrin-gel-selected cancer cells (Fig. 4B, C), which confirmed their cancer stem cell identity. This evidence concerns the gene PROM1 and cancer.